review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CLPT.2006.04.008 |
P698 | PubMed publication ID | 16815312 |
P2093 | author name string | Ute I Schwarz | |
C Michael Stein | |||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | anticoagulation | Q63279445 |
anticoagulant | Q215118 | ||
P304 | page(s) | 7-12 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
P1476 | title | Genetic determinants of dose and clinical outcomes in patients receiving oral anticoagulants | |
P478 | volume | 80 |
Q24322624 | CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant |
Q36981935 | Clinical factors influencing normalization of prothrombin time after stopping warfarin: a retrospective cohort study |
Q92339958 | Genetic risk assessment towards warfarin application: Saudi Arabia study with a potential to predict and prevent side effects |
Q51906653 | High-resolution SNP and haplotype maps of the human gamma-glutamyl carboxylase gene (GGCX) and association study between polymorphisms in GGCX and the warfarin maintenance dose requirement of the Japanese population. |
Q45937530 | Influence of clinical and genetic factors on warfarin dose requirements among Japanese patients. |
Q36336007 | Personalized medicine: is it a pharmacogenetic mirage? |
Q26779038 | Pharmacogenetics of healthy volunteers in Puerto Rico |
Q23919667 | Pharmacogenetics, pharmacogenomics, and individualized medicine |
Q33990441 | Prevalence of combinatorial CYP2C9 and VKORC1 genotypes in Puerto Ricans: implications for warfarin management in Hispanics. |
Q38122099 | The pharmacology of novel oral anticoagulants |
Q37387226 | Trans-Resveratrol Enhances the Anticoagulant Activity of Warfarin in a Mouse Model |
Q37074097 | Use of genetic and nongenetic factors in warfarin dosing algorithms |
Q81887452 | Warfarin pharmacogenetics |
Q33561482 | Warfarin pharmacogenomics |
Search more.